(1)
Werth, V.; Joly, P.; Mimouni, D.; Maverakis, E.; Lahane, P.; Gearhart, L.; Pordeli, P.; Chen, D. A Phase III, Randomized, Double-Blind, Controlled Study (PEMPHIX) to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Patients With Pemphigus Vulgaris. J of Skin 2020, 4, S26.